Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVINT TECHNOLOGIES INC | 21,122,239 | reported | 17 Jun 2024 | tx 3+64,131,698.79 |
| NRX Pharmaceuticals, Inc. | 25,000 | reported | 09 Apr 2025 | tx 12+3,120,876 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Apr 2025 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | NOVINT TECHNOLOGIES INC | 21,122,239 | 0.00 USD | deriv |
| 14 Aug 2023 | GRANT_AWARD | NOVINT TECHNOLOGIES INC | 42,417,309 | — | deriv |
| 14 Aug 2023 | GRANT_AWARD | NOVINT TECHNOLOGIES INC | 592,150.79 | — | deriv |
| 30 Aug 2023 | PURCHASE | NRX Pharmaceuticals, Inc. | 70,000 | 0.29 USD | |
| 16 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 287,812 | 0.99 USD | |
| 18 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 40,408 | 1.10 USD | |
| 17 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 171,780 | 1.08 USD | |
| 21 Oct 2022 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 162,660 | — | deriv |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 1,436,350 | — | |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 208,443 | — | |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 218,423 | — | deriv |